- Exchange: SIX Swiss Ex
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Snapshot for Lonza Group AG (LONN)
| Open: | 70.850 | Day's Range: | 69.950 - 71.200 | Volume: | 151,297 |
|---|---|---|---|---|---|
| Previous Close: | 70.900 | 52wk Range: | 33.794 - 74.900 | 1-Yr Rtn: | +106.32% |
Key Statistics for LONN
| Current P/E Ratio (ttm) | 19.9858 |
|---|---|
| Estimated P/E(12/2013) | 15.1290 |
| Relative P/E vs. SMI | 1.0172 |
| Earnings Per Share (CHF) (ttm) | 3.5200 |
| Est. EPS (CHF) (12/2013) | 4.6500 |
| Est. PEG Ratio | 0.6636 |
| Market Cap (M CHF) | 3,722.93 |
| Shares Outstanding (M) | 52.92 |
| 30 Day Average Volume | 290,649 |
| Price/Book (mrq) | 1.5174 |
| Price/Sale (ttm) | 0.9280 |
| Dividend Indicated Gross Yield | 3.06% |
| Cash Dividend (CHF) | 2.1500 |
| Last Dividend | 04/11/2013 |
| 5 Year Dividend Growth | 4.20% |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for LONN
Company Profile & Key Executives for LONN
Lonza Group AG produces organic fine chemicals, biocides, active ingredients, and biotechnology products. The Company offers custom chemical manufacturing and fermentation processing and manufactures its products for the life sciences, pharmaceuticals, food processing, and agricultural products industries. Lonza operates production sites in Europe, the United States, and China.
| Richard RidingerChief Executive Officer | Toralf A HaagChief Financial Officer |
| Stephan KutzerCOO:Customer Manufacturing | Beat In-AlbonCOO:Life Science Ingredients |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
LONN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page